2021 Revenues ($USD) : $2,545,626,000
2021 R&D spend : $226,598,000
2021 Number of Employees : 8,000
Fiscal Year End : 12/31/2020
Key People : Norman Schwartz, chair, president and CEO; Andrew Last, EVP, chief operating officer; Ilan Daskal, EVP, CFO; Timothy Ernst, EVP, general counsel and secretary; Mike Crowley, EVP, global commercial operations; Annette Tumolo, EVP, president, life sciences; Dara Wright, EVP, president, clinical diagnostics; Ajit Ramalingam, SVP, chief accounting officer.

About the company: Bio-Rad develops and makes products for the life science research and clinical diagnostic markets. Customers include universities, research institutions, hospitals, public health and commercial laboratories, biotechnology firms, pharmaceutical companies, as well as applied laboratories that include food safety and environmental quality. During the third quarter of 2021, the company reported continued demand for products associated with COVID-19 testing and research, though at a more moderate level. –CN